Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
10 01 2023
Historique:
received: 26 04 2022
revised: 12 08 2022
accepted: 22 11 2022
pmc-release: 10 01 2024
pubmed: 16 12 2022
medline: 14 1 2023
entrez: 15 12 2022
Statut: ppublish

Résumé

Obesity-induced chronic liver inflammation is a hallmark of nonalcoholic steatohepatitis (NASH)-an aggressive form of nonalcoholic fatty liver disease. However, it remains unclear how such a low-grade, yet persistent, inflammation is sustained in the liver. Here, we show that the macrophage phagocytic receptor TREM2, induced by hepatocyte-derived sphingosine-1-phosphate, was required for efferocytosis of lipid-laden apoptotic hepatocytes and thereby maintained liver immune homeostasis. However, prolonged hypernutrition led to the production of proinflammatory cytokines TNF and IL-1β in the liver to induce TREM2 shedding through ADAM17-dependent proteolytic cleavage. Loss of TREM2 resulted in aberrant accumulation of dying hepatocytes, thereby further augmenting proinflammatory cytokine production. This ultimately precipitated a vicious cycle that licensed chronic inflammation to drive simple steatosis transition to NASH. Therefore, impaired macrophage efferocytosis is a previously unrecognized key pathogenic event that enables chronic liver inflammation in obesity. Blocking TREM2 cleavage to restore efferocytosis may represent an effective strategy to treat NASH.

Identifiants

pubmed: 36521495
pii: S1074-7613(22)00603-3
doi: 10.1016/j.immuni.2022.11.013
pmc: PMC9839616
mid: NIHMS1855052
pii:
doi:

Substances chimiques

TREM2 protein, human 0
Membrane Glycoproteins 0
Receptors, Immunologic 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-77.e11

Subventions

Organisme : NCI NIH HHS
ID : R01 CA233794
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA255621
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099558
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Gut. 2019 Mar;68(3):533-546
pubmed: 29374630
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
Annu Rev Pathol. 2018 Jan 24;13:321-350
pubmed: 29414249
Life Sci. 2019 Nov 1;236:116464
pubmed: 31078546
J Lipid Res. 2015 Dec;56(12):2359-71
pubmed: 26482537
Nature. 2012 Feb 01;482(7384):179-85
pubmed: 22297845
Mol Med. 2007 Nov-Dec;13(11-12):553-60
pubmed: 17673941
Hepatology. 2022 Jun 16;:
pubmed: 35712786
Hepatology. 2015 May;61(5):1565-78
pubmed: 25581263
EMBO Mol Med. 2017 Oct;9(10):1356-1365
pubmed: 28855300
Nature. 2018 Aug;560(7717):198-203
pubmed: 30046112
Front Immunol. 2021 Feb 08;11:616044
pubmed: 33628208
Immunity. 2020 Jun 16;52(6):1057-1074.e7
pubmed: 32362324
Nature. 2017 Nov 16;551(7680):340-345
pubmed: 29144460
Am J Clin Nutr. 2017 Jun;105(6):1272-1282
pubmed: 28446501
J Biol Chem. 2013 Nov 15;288(46):33027-36
pubmed: 24078628
J Hepatol. 2022 Nov;77(5):1373-1385
pubmed: 35750138
Cell Rep. 2021 Jan 12;34(2):108626
pubmed: 33440159
J Immunol. 2006 Aug 15;177(4):2051-5
pubmed: 16887962
Dig Dis Sci. 2016 May;61(5):1294-303
pubmed: 26841783
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
J Physiol. 2022 Oct;600(20):4485-4501
pubmed: 36044273
Gut. 2011 Oct;60(10):1394-402
pubmed: 21270117
J Hepatol. 2018 Aug;69(2):385-395
pubmed: 29572095
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Front Immunol. 2018 Dec 19;9:2980
pubmed: 30619336
J Immunol. 1995 Jun 15;154(12):6533-40
pubmed: 7759886
FASEB J. 2008 Aug;22(8):2629-38
pubmed: 18362204
Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):349-364
pubmed: 29740166
Cell Metab. 2019 Jan 8;29(1):18-26
pubmed: 30449681
J Immunol. 2000 May 15;164(10):4991-5
pubmed: 10799849
J Biol Chem. 2015 Dec 25;290(52):30684-96
pubmed: 26534962
J Exp Med. 2003 Aug 18;198(4):669-75
pubmed: 12925681
Cell Host Microbe. 2016 Nov 9;20(5):561-571
pubmed: 27832587
J Gastroenterol Hepatol. 2012 Apr;27(4):789-96
pubmed: 22188204
Immunity. 2016 Feb 16;44(2):287-302
pubmed: 26872696
Cell. 2019 Oct 31;179(4):829-845.e20
pubmed: 31675496
Cell. 2003 Jun 13;113(6):717-30
pubmed: 12809603
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Am J Physiol Gastrointest Liver Physiol. 2014 Mar;306(6):G496-504
pubmed: 24436353
Nat Commun. 2021 Feb 26;12(1):1322
pubmed: 33637724
Neurosci Lett. 2017 Nov 1;660:109-114
pubmed: 28923481
J Exp Med. 2015 May 4;212(5):681-97
pubmed: 25897174
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
J Neuroimmunol. 2005 Mar;160(1-2):92-101
pubmed: 15710462
J Immunol. 2006 Sep 15;177(6):3520-4
pubmed: 16951310
J Transl Med. 2019 Sep 2;17(1):300
pubmed: 31477129
Hepatology. 2014 Aug;60(2):531-44
pubmed: 24668763
Front Med. 2013 Jun;7(2):242-54
pubmed: 23681888
Circ Res. 2008 Apr 25;102(8):950-8
pubmed: 18323526
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cell. 2020 Jun 11;181(6):1207-1217
pubmed: 32531244
Hepatology. 2010 Jan;51(1):92-102
pubmed: 19998387
Br J Pharmacol. 2006 Jun;148(4):469-77
pubmed: 16633358
Hepatol Res. 2021 May;51(5):614-626
pubmed: 33586816
Acta Pharm Sin B. 2022 Apr;12(4):1885-1898
pubmed: 35847502
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Biol Chem. 2008 Feb 29;283(9):5296-305
pubmed: 18089568
Sci Rep. 2017 Sep 12;7(1):11289
pubmed: 28900132
Redox Biol. 2018 May;15:86-96
pubmed: 29220698
Gut. 2021 Jul;70(7):1345-1361
pubmed: 32907830
J Mol Med (Berl). 2014 Oct;92(10):1069-82
pubmed: 24861026
Med (N Y). 2021 Jul 09;2(7):836-850.e10
pubmed: 34318286
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
Nat Med. 2007 Nov;13(11):1324-32
pubmed: 17952090
Nature. 2009 Sep 10;461(7261):282-6
pubmed: 19741708
EMBO Mol Med. 2017 Oct;9(10):1366-1378
pubmed: 28855301
Nature. 2022 Mar;603(7902):736-742
pubmed: 35264794
Lab Invest. 2012 May;92(5):713-23
pubmed: 22411067
Exp Mol Med. 2017 May 12;49(5):e331
pubmed: 28496201
Sci Rep. 2019 Aug 29;9(1):12541
pubmed: 31467298
Nat Immunol. 2015 Sep;16(9):907-17
pubmed: 26287597
Immunity. 2019 May 21;50(5):1149-1162
pubmed: 31117011
Sci Rep. 2017 Sep 11;7(1):11118
pubmed: 28894284
Transgenic Res. 1999 Aug;8(4):265-77
pubmed: 10621974
Cell. 2011 Sep 30;147(1):173-84
pubmed: 21962514
Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232
pubmed: 26405687
J Mol Biol. 2017 Jun 2;429(11):1607-1629
pubmed: 28432014
Hepatol Commun. 2018 Sep 07;2(9):1005-1020
pubmed: 30202816
Food Chem Toxicol. 2017 May;103:111-121
pubmed: 28257781
Cancer Cell. 2014 Sep 8;26(3):331-343
pubmed: 25132496
Immunity. 2020 Sep 15;53(3):641-657.e14
pubmed: 32888418
Gastroenterology. 2019 Mar;156(4):1156-1172.e6
pubmed: 30445007
Mol Cell. 2019 Aug 8;75(3):644-660.e5
pubmed: 31398325
Mol Pharmacol. 2008 Nov;74(5):1308-18
pubmed: 18708635
Cancer Cell. 2016 Dec 12;30(6):879-890
pubmed: 27960085
J Magn Reson Imaging. 2015 May;41(5):1218-27
pubmed: 24916329
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Cell Microbiol. 2018 May;20(5):e12836
pubmed: 29498184
Nat Rev Gastroenterol Hepatol. 2015 Jul;12(7):387-400
pubmed: 26055245
Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G825-34
pubmed: 21836057
Cell. 2019 Jul 25;178(3):686-698.e14
pubmed: 31257031
J Immunol. 2010 Nov 15;185(10):6317-28
pubmed: 20962261
Annu Rev Biochem. 2009;78:743-68
pubmed: 19231986
Sci Rep. 2016 Aug 26;6:32119
pubmed: 27562371
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
J Clin Invest. 2021 Feb 15;131(4):
pubmed: 33586673
Gastroenterology. 2003 Aug;125(2):437-43
pubmed: 12891546
Diabetes. 2021 Sep;70(9):2042-2057
pubmed: 33627323
Nat Rev Immunol. 2017 May;17(5):306-321
pubmed: 28317925
Blood. 2010 Apr 29;115(17):3531-40
pubmed: 20197547
Sci Rep. 2019 May 17;9(1):7508
pubmed: 31101881
Sci Signal. 2010 May 18;3(122):ra38
pubmed: 20484116
J Hepatol. 2012 Mar;56(3):704-13
pubmed: 22120206
Diabetes. 2007 Dec;56(12):2863-71
pubmed: 17728375
Nat Commun. 2019 Mar 25;10(1):1365
pubmed: 30911003

Auteurs

Xiaochen Wang (X)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Qifeng He (Q)

Department of General Surgery, Nanjing First Hospital, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing 210006, Jiangsu, China.

Chuanli Zhou (C)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Yueyuan Xu (Y)

Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Center for Advanced Genomic Technologies, Duke University Medical Center, Durham, NC 27710, USA.

Danhui Liu (D)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Naoto Fujiwara (N)

Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Naoto Kubota (N)

Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Arielle Click (A)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Polly Henderson (P)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Janiece Vancil (J)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Cesia Ammi Marquez (CA)

Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Ganesh Gunasekaran (G)

Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Myron E Schwartz (ME)

Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Parissa Tabrizian (P)

Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Umut Sarpel (U)

Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Maria Isabel Fiel (MI)

Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Yarui Diao (Y)

Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Center for Advanced Genomic Technologies, Duke University Medical Center, Durham, NC 27710, USA.

Beicheng Sun (B)

Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, China.

Yujin Hoshida (Y)

Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Shuang Liang (S)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: shuang.liang@utsouthwestern.edu.

Zhenyu Zhong (Z)

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: zhenyu.zhong@utsouthwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH